✦ LIBER ✦

TCT-279: Baseline Clinical and Angiographic Characteristics of the Patient Related Outcomes WiTh Endeavor Versus Cypher STenting (PROTECT) Trial

Book ID: 119269755
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 150 KB
Volume: 56
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2010.08.303

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of the Patient Rela

Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

✍ Edoardo Camenzind; William Wijns; Laura Mauri; Eric Boersma; Keyur Parikh; Volkh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB